Content about Don Wetherhold

November 11, 2013

Aprecia Pharmaceuticals Co. has appointed Don Wetherhold as its CEO, the company said Monday.

MASON, Ohio — Aprecia Pharmaceuticals Co. has appointed Don Wetherhold as its CEO, the company said Monday.

Wetherhold is returning to Aprecia after a term as SVP long-term care at Omnicare; prior to that, he was Aprecia's corporate commercialization officer.

"We are thrilled to have Don back at Aprecia, and we look forward to the leadership he will bring to this role," Aprecia chairman E. Thomas Arington. "Don was instrumental in devising our commercialization strategy at Aprecia."